Predictors of poor outcome in tocilizumab treated patients with Sars-CoV-2 related severe respiratory failure: A multicentre real world study.

Saved in:
Bibliographic Details
Title: Predictors of poor outcome in tocilizumab treated patients with Sars-CoV-2 related severe respiratory failure: A multicentre real world study.
Authors: Masotti L; Internal Medicine II, San Giuseppe Hospital, Empoli, Italy. Electronic address: luca.masotti@tin.it., Landini G; Internal Medicine, Santa Maria Nuova Hospital, Florence, Italy., Panigada G; Internal Medicine, SS Damiano and Cosma Hospital, Pescia, Italy., Grifoni E; Internal Medicine II, San Giuseppe Hospital, Empoli, Italy., Tarquini R; Internal Medicine I, San Giuseppe Hospital, Empoli, Italy., Cei F; Internal Medicine I, San Giuseppe Hospital, Empoli, Italy., Cimolato BMA; Internal Medicine, Santa Maria Nuova Hospital, Florence, Italy., Vannucchi V; Internal Medicine, Santa Maria Nuova Hospital, Florence, Italy., Di Pietro M; Infectious Diseases, Santa Maria Annunziata Hospital, Florence, Italy., Piani F; Internal Medicine, Santa Maria Annunziata Hospital, Florence, Italy., Fortini A; Internal Medicine, San Giovanni di Dio Hospital, Florence, Italy., Faraone A; Internal Medicine, San Giovanni di Dio Hospital, Florence, Italy., Nenci G; Internal Medicine II, San Jacopo Hospital, Pistoia, Italy., Cipollini F; Internal Medicine I, San Jacopo Hospital, Pistoia, Italy., Blanc P; Infectious Diseases, San Jacopo Hospital, Pistoia, Italy., Lotti P; Internal Medicine, Santo Stefano Hospital, Prato, Italy., Di Natale M; Internal Medicine, Santo Stefano Hospital, Prato, Italy., Risaliti F; Internal Medicine, Santo Stefano Hospital, Prato, Italy., Aquilini D; Infectious Diseases, Santo Stefano Hospital, Prato, Italy., Seravalle C; Internal Medicine, Borgo San Lorenzo Hospital, Florence, Italy., Bribani A; Internal Medicine, Serristori Hospital, Figline Valdarno, Italy., Farsi A; Allergology and Clinical Immunology, Ex Misericordia and Dolce Hospital, Prato, Italy., Micheletti I; Internal Medicine II, San Giuseppe Hospital, Empoli, Italy., Cioni E; Internal Medicine II, San Giuseppe Hospital, Empoli, Italy., Pelagalli G; Internal Medicine II, San Giuseppe Hospital, Empoli, Italy., Mattaliano C; Internal Medicine II, San Giuseppe Hospital, Empoli, Italy., Pinto G; Internal Medicine II, San Giuseppe Hospital, Empoli, Italy., Madonia EM; Internal Medicine II, San Giuseppe Hospital, Empoli, Italy., Sivieri I; Internal Medicine II, San Giuseppe Hospital, Empoli, Italy., Mannini M; Internal Medicine II, San Giuseppe Hospital, Empoli, Italy., Valoriani A; Internal Medicine I, San Giuseppe Hospital, Empoli, Italy., Brancati S; Internal Medicine I, San Giuseppe Hospital, Empoli, Italy., Rosselli M; Internal Medicine I, San Giuseppe Hospital, Empoli, Italy., Pavone E; SOC Governance Farmaceutica and Appropriatezza Prescrittiva, Azienda USL Toscana Centro, Italy., Burla MC; SOC Governance Farmaceutica and Appropriatezza Prescrittiva, Azienda USL Toscana Centro, Italy., Sergi A; SOC Monitoraggio and Programmazione performance clinico-assistenziale, Azienda USL Toscana Centro, Italy.
Corporate Authors: Department of Medical Specialties of Azienda USL Toscana Centro Covid-19 Group
Source: International immunopharmacology [Int Immunopharmacol] 2022 Jun; Vol. 107, pp. 108709. Date of Electronic Publication: 2022 Mar 18.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-1705
DOI:10.1016/j.intimp.2022.108709